Abstract
Introduction Analysis of cough sounds have the potential to give a clue regarding the underlying respiratory disease. The Swaasa AI platform using artificial intelligence technology can analyze the cough sounds and provides an output using cough as a marker. The Swaasa AI platform comes under the category of Software As a Medical Device (SaMD), the device can detect underlying respiratory condition as normal vs abnormal, the pattern of disease condition (obstructive, restrictive or normal), the severity of pattern (mild, moderate, severe) and presence of disease conditions for Asthma, COPD, ILD and Bronchiectasis.
Methods Patients (age >= 18 years) presenting to our departments with respiratory symptoms were prospectively recruited into the study. The patient’s cough sound was recorded by a mobile device in which the Swaasa AI platform was installed. Spirometry was done and patients’ clinical diagnosis was taken as reference standard for comparison. Polychotomous variables were analyzed in binary form as normal and abnormal. Multi-class outcomes were defined as obstructive, restrictive, or normal pattern, mild-moderate-severe as pattern severity or disease conditions like Asthma, COPD, ILD and Bronchiectasis.
Results We recruited 2179 patients with respiratory diseases and 827 normal individuals. Sixty-two percent of them were males. The Swaasa AI platform has 90% accuracy in distinguishing normal versus abnormal (having respiratory condition) as well as distinguishing normal from abnormal spirometry. The performance was consistent across demographic parameters such as age, gender, and BMI. The accuracy for multi-class outcomes were between 79%-84% for spirometry pattern and 76%-84.5% for pattern severity and 83%-93% for disease type classification.
Conclusion Swaasa commends an elevated level of precision in classifying normal and abnormal conditions across demographic subgroups indicating its promise as a screening tool. While the accuracy measures emphasize further refinement to ensure consistent high performance across disease scenarios and severity levels, the study shows Swaasa’s reasonable potential in identification of specific respiratory diseases and their severity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study is funded by BIRAC
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The IRB of Christian Medical College, Vellore, India gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
While submitted BMC, as per author guidelines we have updated, 1. Abstract and keywords 2. Author contribution 3. Added limitation section 4. Edited conclusion section
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Data Availability
Due to the nature of this research, participants of this study did not agree for their data to be shared publicly. However, the detailed analysis can be shared by the author “NRS” upon reasonable request.
